The U.S. might get first access to Sanofis coronavirus vaccine because the country coughed up more money than Europe, according to the French drug companys CEO.
“The U.S. government has the right to the largest pre-order because its invested in taking the risk,” Sanofi Chief Executive Officer Paul Hudson told Bloomberg in an interview published Wednesday.
The U.S.s Biomedical Advanced Research and Development Authority (BARDA) has put $30 million toward one of Sanofis two vaccine candidates, which is also using technology from GlaxoSmithKline (GSK).
Because of this help, the U.S. expects “that if weve helped you manufacture the doses at risk, we expect to get the doses first,” Hudson said.
Meanwhile, the Sanofi CEO warned that Europe risks falling behind the U.S. and China.
“Those two powerhouse economies will be vaccinated first, which is why it became so important to try to create a debate in Europe to say, Dont let Europe be left behind,'” he said.
In April, Hudson slammed the EU for its lack of coordination on vaccine research.
“Ive been campaigning in Europe to say the U.S. will get vaccines first,” Hudson said. “ThatsRead More – Source